Advisory Services Network’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-2,060
Closed -$9.9K – 2727
2026
Q1
$9.9K Buy
+2,060
New +$13.3K ﹤0.01% 3569
2025
Q4
– Sell
-5,060
Closed -$29.7K – 2366
2025
Q3
$29.7K Buy
+5,060
New +$35.9K ﹤0.01% 2755
2024
Q1
– Sell
-5
Closed -$82 – 1940
2023
Q4
$82 Buy
+5
New +$93 ﹤0.01% 3794
2023
Q2
– Sell
-11
Closed -$157 – 1939
2023
Q1
$157 Hold
11
– – ﹤0.01% 3871
2022
Q4
$123 Sell
11
-276
-96% -$4.55K ﹤0.01% 3898
2022
Q3
$5K Buy
+287
New +$7.77K ﹤0.01% 1350

Other funds holding HELP

Advisory Services Network's HELP Position: Q2 2026 in Review

Advisory Services Network sold out of Helus Pharma Inc. Common Stock (HELP) in Q2 2026, closing a stake of 2,060 shares — an estimated $9.9K sold.

Advisory Services Network first reported a position in HELP in Q3 2022 and held it in 6 quarters. The position peaked at $29.7K in Q3 2025. 99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • Advisory Services Network reported no remaining Helus Pharma Inc. Common Stock position as of Q2 2026 after selling out during the quarter.
  • Advisory Services Network sold 2,060 Helus Pharma Inc. Common Stock shares in Q2 2026, an estimated $9.9K.
  • Advisory Services Network first reported a position in Helus Pharma Inc. Common Stock in Q3 2022 and held it in 6 quarters.
  • Advisory Services Network's Helus Pharma Inc. Common Stock position peaked at $29.7K in Q3 2025.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.